(Circulation. 1997;96:676-682.)
© 1997 American Heart Association, Inc.
Articles |
Glycogen Metabolism in the Aerobic Hypertrophied Rat Heart
From the Cardiovascular Research Laboratory, University of British Columbia, Vancouver (M.F.A., S.L.H., R.B.W., S.R.G., D.R.E.), and the Cardiovascular Disease Research Group, University of Alberta, Edmonton (G.D.L.), Canada.
Background Rates of glycolysis from exogenous glucose are accelerated in hypertrophied hearts. In this study, we determined whether alterations in the metabolism of glycogen, an endogenous storage form of glucose, also occur in hypertrophied hearts.
Methods and Results Rates of glycolysis ([3H]H2O production) and oxidation ([14C]CO2 production) from exogenous glucose and glycogen were measured in isolated working hearts from control and aortic-banded rats. Hearts in which glycogen was prelabeled with [5-3H]- or [U-14C]glucose were perfused with buffer containing 11 mmol/L [5-3H]- or [U-14C]glucose (different from the isotope used to prelabel glycogen), 0.4 mmol/L palmitate, 0.5 mmol/L lactate, and 100 µU/mL insulin. Rates of glycolysis from exogenous glucose were greater (3471±114 versus 2665±194 nmol glucose·min-1·g dry wt-1, P<.05, n=4 to 6, mean±SEM) and rates of exogenous glucose oxidation (445±36 versus 619±16 nmol glucose·min-1·g dry wt-1, P<.05, n=4 to 6) were lower in hypertrophied hearts than in control hearts. Rates of glycolysis and oxidation from glycogen were not different between hypertrophied and control hearts. A greater proportion of glycogen was oxidized (80% to 100%) than the proportion of exogenous glucose oxidized (13% to 24%) in both groups. Additionally, 10.5±1.4 and 12.3±1.0 µmol/g dry wt of glycogen was synthesized in hypertrophied and control hearts, respectively, indicating that simultaneous synthesis and degradation (ie, glycogen turnover) occurred in both groups.
Conclusions Thus, aerobic myocardial glycogen metabolism in the hypertrophied heart is similar to that observed in the normal heart even though exogenous glucose metabolism is altered in the hypertrophied heart.
Key Words: myocardium • hypertrophy • glycogen • metabolism
This article has been cited by other articles:
 |
|
 |
|
  R. Saeedi, H. L. Parsons, R. B. Wambolt, K. Paulson, V. Sharma, J. R. B. Dyck, R. W. Brownsey, and M. F. Allard Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2497 - H2506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Barillas, I. Friehs, H. Cao-Danh, J. F. Martinez, and P. J. del Nido Inhibition of Glycogen Synthase Kinase-3{beta} Improves Tolerance to Ischemia in Hypertrophied Hearts Ann. Thorac. Surg., July 1, 2007; 84(1): 126 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. An, G. Kewalramani, D. Qi, T. Pulinilkunnil, S. Ghosh, A. Abrahani, R. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues {beta}-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1120 - E1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Burelle, R. B. Wambolt, M. Grist, H. L. Parsons, J. C. F. Chow, C. Antler, A. Bonen, A. Keller, G. A. Dunaway, K. M. Popov, et al. Regular exercise is associated with a protective metabolic phenotype in the rat heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1055 - H1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Qi, T. Pulinilkunnil, D. An, S. Ghosh, A. Abrahani, J. A. Pospisilik, R. Brownsey, R. Wambolt, M. Allard, and B. Rodrigues Single-Dose Dexamethasone Induces Whole-Body Insulin Resistance and Alters Both Cardiac Fatty Acid and Carbohydrate Metabolism Diabetes, July 1, 2004; 53(7): 1790 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Longnus, R. B. Wambolt, H. L. Parsons, R. W. Brownsey, and M. F. Allard 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R936 - R944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Friehs and P. J. del Nido Increased susceptibility of hypertrophied hearts to ischemic injury Ann. Thorac. Surg., February 1, 2003; 75(2): S678 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Wambolt, G. D. Lopaschuk, R. W. Brownsey, and M. F. Allard Dichloroacetate improves postischemic function of hypertrophied rat hearts J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1378 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Allard, R. B. Wambolt, S. L. Longnus, M. Grist, C. P. Lydell, H. L. Parsons, B. Rodrigues, J. L. Hall, W. C. Stanley, and G. P. Bondy Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E487 - E493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Kilgore, C. F. Shwartz, M. A. Gallagher, R. P. Steffen, R. S. Mosca, and S. F. Bolling RSR13, a Synthetic Allosteric Modifier of Hemoglobin, Improves Myocardial Recovery Following Hypothermic Cardiopulmonary Bypass Circulation, November 9, 1999; 100 (2009): II-351 - II-356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-I. Jung, L. Sieverding, J. Breuer, T. Hoess, S. Widmaier, O. Schmidt, M. Bunse, F. van Erckelens, J. Apitz, O. Lutz, et al. 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy Circulation, June 30, 1998; 97(25): 2536 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Leong, M. Grist, H. Parsons, R. B. Wambolt, G. D. Lopaschuk, R. Brownsey, and M. F. Allard Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact? Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1039 - E1045. [Abstract] [Full Text] [PDF]
|
|